Abomics is a Finnish expert company that empowers physicians with tools for informed decision-making. Our focus lies in the field of personalized health care, specifically pharmacogenetics. Pharmacogenetics combines genetics with pharmacology, allowing us to tailor medication to individual patients based on their genetic makeup. Scientific evidence demonstrates that personalized medication improves clinical outcomes for patients and enhances cost efficiency for society. Abomics simplifies pharmacogenetics for doctors by providing patient-specific reports based on blood tests. These reports indicate whether a specific medicine is suitable for a patient and how the dosage should be adjusted. Our main customers include clinical laboratories and companies offering electronic health record (EHR) and database solutions to healthcare organizations.